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This newsletter was jointly developed and 
subject to editorial review by Jefferson 
School of Population Health and Lilly 
USA, LLC, and is supported through 
funding by Lilly USA, LLC.  The content 
and viewpoints expressed are those of the 
individual authors, and are not necessarily 
those of Lilly USA, LLC or the Jefferson 
School of Population Health.
Welcome back to Prescriptions for 
Excellence in Health Care, a second 
volume of supplements to our Health 
Policy Newsletter devoted exclusively to 
the quality improvement agenda in the 
United States. This special issue focuses 
on a relatively new but increasingly 
important aspect of health care quality – 
namely, the governing board’s leadership 
role and responsibilities vis-à-vis 
quality assurance and improvement 
throughout their organization. 
Until recently, hospital and health 
system boards were comprised mainly 
of businessmen and meetings focused 
primarily on a “bottom line” defined 
solely in financial terms. The policy 
debates that followed in the wake of  
the Institute of Medicine’s report, 
Crossing the Quality Chasm, brought 
about changes in the 21st century 
boardroom as well as at the point  
of care. 
Today, the Centers for Medicare 
and Medicaid Services (CMS) and 
professional oversight organizations 
require private and nonprofit institution 
boards to demonstrate leadership 
in quality and patient safety. Board 
composition is changing, with growing 
numbers of medical professionals 
taking seats at the table. Quality, 
which rarely made an appearance 
at board meetings in prior years, is 
often at the top of the agenda. 
The articles in Section I of this issue 
discuss governance from 6 different 
perspectives. The first article, “The 
Governing Board’s Role in the Quality 
Agenda: An Overview,” serves as a 
primer and lays the groundwork for 
other articles in the section. The second 
article, “Hospital Boards: Bringing 
Quality to the Table,” highlights 
the important steps that must be 
taken and offers practical advice for 
incorporating quality at the board level.  
Finance remains a primary responsibility 
of the board, and in the third article, 
“Quality Improvement and the Bottom 
Line,” Dr. Carpenter discusses quality 
improvement with an eye toward 
expenses, revenue, and income. The 
fourth article, “Ethics, Culture, and the 
Board,” examines these and associated 
Editorial
All Boards Aboard the Quality Train! 
By David B. Nash, MD, MBA
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behavioral elements that present 
challenges for today’s governing boards. 
“Nonprofit Community Health  
System Board Engagement in CEO 
and Board Evaluation,” reports on the 
results of a large-scale, comprehensive 
study of the structures, practices, 
and cultures of community health 
system governing boards with 
respect to accepted definitions of 
good governance. The final article 
on governance, “The Future of 
Boards: White Water Ahead,” serves 
as a reminder that change – even 
for the better – is never without 
turbulence and points out some 
submerged rocks downstream.
The 3 articles in Section II call 
attention to other important work 
being accomplished in the health care 
quality arena. The first, “Reforming 
Camden’s Health Care System – One 
Patient at a Time,” is an amazing 
success story from the front lines of 
medicine and a valuable lesson in how, 
even in a marginalized community, 
health quality can be improved through 
intelligent use of health information 
technology tools, communication, 
cooperation, and application of the 
principles of population health. 
“Physician Quality Performance 
Initiative (PQRI): Theory and Practice” 
provides valuable insight into CMS’ 
pay-for-performance program via 
the experience of 1 large hospital.  
The final article, “Improving Quality 
and Safety through Convenient 
Care Clinics,” recounts the process 
by which retail clinics made quality 
and patient safety a top priority.
I am very proud of this information-
rich issue and the work of these 
talented authors. For readers who 
would like more detail on governance, 
a number of contributors to this issue 
also authored chapters for a text on 
the subject (Governance for Health 
Care Providers: The Call to Leadership. 
Nash DB, Oetgen WJ, Pracilio VP, 
eds., Taylor & Francis, Inc., 2008). 
As always, I am interested in 
your feedback; you can reach 
me by email at: david.nash@
jefferson.edu or visit my blog at: 
nashhealthpolicy@blogspot.com. 
David B. Nash, MD, MBA is Founding 
Dean and the Dr. Raymond C. and 
Doris N. Grandon Professor, Jefferson 
School of Population Health.
Being in the business of 
discovering, developing, 
manufacturing, and marketing 
medicines is a privilege. At  
Eli Lilly and Company, we 
understand that we must earn  
this privilege—and the trust  
of our customers—every day.
A relentless focus on quality 
is one of the most important 
ways we earn this trust.
While historically our quality 
organization has been associated 
mainly with manufacturing, in 
recent years we have set a course 
to establish quality systems 
throughout our enterprise.
Our goal is nothing less than 
making quality an integrated and 
permanent part of our culture 
in every part of our business. 
Key to this transformation is 
the widespread use of science-
based principles such as risk 
management and quality by design.
For a pharmaceutical company, 
quality by design can be described 
in 2 steps. First, you must design 
your products to meet specific 
targets—in this case, targets of 
clinical performance as defined 
by your customers and patients. 
Then, you must design all of 
your processes, from R&D 
through post-marketing, to 
consistently deliver a product 
that meets the attributes 
necessary for this performance. 
It is not hard to see how the  
use of quality tools in a truly 
integrated fashion can result in 
improved patient safety and  
better outcomes. In fact, we  
are implementing a Safety and  
Efficacy Quality System to span 
clinical development, marketing, 
and pharmacovigilance. Our 
goal with this system is to 
create global quality standards 
wherever possible, then integrate 
them across boundaries. While 
this effort is still relatively new, 
already many organizations and 
hundreds of people are involved, 
from clinical research physicians 
to the leaders of our marketing 
affiliates to business partners 
and vendors to regulators.
Of course, manufacturing remains 
integral to providing products  
that are safe and high quality. 
Within our global manufacturing 
network, which includes more 
than 20 sites, 10,000 employees, 
and numerous contract 
manufacturing organizations,  
we have moved beyond “basic” 
A Message from Lilly
In Pursuit of a Quality Culture
By Fionnuala Walsh, PhD
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quality practices and into 
a continuous improvement 
mode. Having seen tangible 
improvements among the 
metrics for manufacturing 
excellence (these metrics include 
deviations, backlog items, 
and factory losses), we have 
demonstrated effectiveness. Now, 
we are challenging ourselves 
to achieve efficiency as well.
More than 30 years ago, a Lilly 
advertisement appearing in 
popular magazines depicted 
a bottle of pills beneath the 
headline, “The one you take 
is never tested.” This rather 
provocative statement was our 
way of expressing confidence 
in the quality of every step we 
take leading to the moment 
when our products reach 
their intended audience. 
Today we are working to reinstill 
this same level of confidence by 
building a quality culture. The  
key differences between then 
and now are that we have better 
tools at our disposal, a stronger 
commitment to enterprise-wide  
quality, and, perhaps most  
important, the knowledge that 
quality can and does lead to  
better outcomes for patients. 
Fionnuala Walsh is Vice President,  
Quality, Eli Lilly and Company.
The Governing Board’s Role in the Quality Agenda: An Overview
By William J. Oetgen, MD, MBA 
The responsibility of the governing 
board in setting the quality agenda  
is a subject of wide currency among 
health care organizations. Today’s 
hospital and health system boards 
are continually reminded that their 
responsibility for quality care and 
patient safety – often viewed as a 
specific subset of quality care – is 
foremost on the minds of patients, 
payers, providers, and regulators. But 
quality care and patient safety have 
not always been so prominent on the 
agendas of health care boards. It is 
instructive to review this ascending 
responsibility from a historical 
perspective, from the viewpoint 
of current mandates, and from a 
speculative look into the future.
Historical Perspective: In a recent 
report, Joshi and Hines1 discussed 
governance board issues of quality  
and safety. A query of articles related 
to this report produced a sample list 
of 699 references. While these articles 
were all related to board governance 
functions and responsibilities, not all  
of them were specifically concerned 
with quality and patient safety.  
Figure 1 shows the publication dates 
of these articles by decade and the 
proportion of the articles that were 
concerned with quality or patient 
safety. These data reveal a surge in the 
publication of board governance-related 
articles in the current decade and a 
modest rise in the proportion of papers 
that are specifically concerned with the 
topics of quality and patient safety. 
In the decade following the 1980 
publication of Donabedian’s 
classic book on health care quality 
(Explorations in Quality Assessment and 
Monitoring, Volume I. The Definition of 
Quality and Approaches to its Assessment), 
there was only a modest increase in 
the number and proportion of quality-
related articles listed in our sample. 
Figure 1 shows that the proportion of 
(continued on page 4)
Figure 1. Published Articles Related to Governance Board Functions and Responsibilities
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quality-related articles in the sample 
was 12.3% in the 1970s, 14.9% in 
the 1980s, and 14.1% in the 1990s. 
A closer look at the publications from 
the 2000s shows the interest in quality 
and safety rising sharply over the 
decade (Figure 2). In the first 2 years  
of the decade, fewer than 20% 
of articles were concerned with 
quality and patient safety, whereas 
nearly half of the publications 
were devoted to these topics in 
the last 2 years. This suggests a 
growing interest in governance 
boards’ functions concerning 
quality of care and patient safety.
The evolution of board function over 
the past half century can be traced 
by reviewing the titles of the 699 
publications chronologically. In the 
1950s, articles were concerned with 
topics such as hospital décor, board 
responsibilities, hospital food service 
(perhaps one of the first board “quality” 
functions), and the board’s relationship 
with nurses. A 1954 article suggested 
that all hospital boards should include 
physicians as members, and the concept 
of boards’ interest in quality first 
appears in the 1960s.  In our sample, 
specific mention of incorporating 
quality committees within board 
structures occurs in 1977, and it is 
apparent that the “quality buck” stops 
with the board by the late 1970s.
From 1980 through the 1990s, the 
concepts of board responsibility, quality 
of care, and patient safety underwent 
refinement. In particular, the concept 
of quality care was broadened to 
include more stakeholders; nurses 
were invited to participate as board 
members; and patient satisfaction 
became a governance concern. During 
this period, the concept of quality 
assurance evolved from total quality 
management to continuous quality 
improvement. Boards’ responsibility for 
all of these processes continued to be 
reflected in the published literature.
Since the publication of the Institute 
of Medicine report in 2000 (Kohn 
LT, Corrigan JM, Donaldson MS, 
eds. To Err is Human: Building a Safer 
Health System), board attention has 
become focused on patient safety 
and medical error reduction. Other 
current quality-related topics of 
board interest are public reporting 
of quality data and the logical nexus 
of finance and quality care, the pay-
for-performance movement.
Over the 60-year span of the 699 
publications in the sample, the concept 
of board responsibility for health care 
quality has evolved from relatively 
trivial concerns (eg, hospital décor) 
to the revolutionary concept of pay 
for performance with its potentially 
adverse financial implications. 
Current Mandates:  Three national 
organizations provide mandates for 
board involvement in quality and 
patient safety: the Joint Commission, 
the National Quality Forum, and the 
Institute for Healthcare Improvement.
The Joint Commission requires 
that governing boards promote a 
culture of quality and safety in their 
organizations. Boards must assure 
that their organizations participate 
in measurement and improvement 
efforts for quality and safety indicators, 
allocate resources so that these 
functions can be accomplished, and 
hold management accountable for 
that accomplishment. Moreover, the 
Joint Commission requires that care 
quality and patient safety be specifically 
addressed in board meetings.2 
The National Quality Forum asserts 
that governing boards are responsible 
for ensuring the quality of health 
care provided in their institutions. 
To that end, boards should enable 
evaluations of their own effectiveness 
in: enhancing quality; developing a 
“quality literacy” of safety, clinical 
care, and outcomes; and overseeing 
their institutions’ participation 
in national quality measurement 
and improvement programs.3
The Institute for Healthcare Improvement 
recommends that health care governing 
boards set and communicate specific 
organizational improvement goals, 
integrate those improvement goals with 
strategic goals, and regularly review key 
metrics and adverse events. Governing 
boards should provide resources for 
the achievement of these goals and 
hold management accountable for 
the attainment of these goals.4 
The common ground of mandates from 
these 3 organizations for governing 
board responsibilities for quality is to:
•   promote a culture of quality 
and safety
•   make quality and safety 
prominent on the board agenda 
and promote board education
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•   ensure organizational 
measurement and improvement 
activities and participate in 
nationally based projects
•   monitor the activities and their results
•   review adverse events
•  provide financial resources
•  hold management accountable
•  hold themselves accountable
The Future: Based on a review of the 
past and a look at the current mandates, 
what might the future hold for 
governing boards regarding the issues 
of quality and patient safety? Future 
governing boards will be required to 
lead by example. They will be expected 
to educate themselves and to achieve 
a sophisticated knowledge of the 
principles of quality care and patient 
safety. This will be accomplished 
by upgrading the knowledge of 
individual board members and 
by adding board members with 
professional expertise in quality 
management and in safety processes. 
Future boards will spend 
proportionately more time on issues 
of quality of care and patient safety. 
They will assess themselves more 
rigorously in these efforts to assure 
that all their organizations’ functions 
are of the highest possible quality. As 
boards become subject to increasing 
scrutiny from outside agencies and 
other parties, they also stand to reap the 
benefits – or suffer the consequences 
– of increased public disclosure. 
While financial oversight will continue 
to be of paramount importance to 
future boards, its relative importance 
will diminish. “Increasingly, the role 
of the governing body in quality and 
patient safety oversight is being viewed 
as a fiduciary responsibility at least 
equal to its financial oversight role.”4
William J. Oetgen, MD, MBA, is Director 
of MedStar Health, Inc. He can be 
reached at: oetgenw@georgetown.edu.
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Hospital Boards: Bringing Quality to the Table 
By Kanak Gautam, PhD
(continued on page 6)
Ever since 1999, when the Institute of 
Medicine reported an estimate of up 
to 98,000 preventable hospital deaths 
annually in its report Measuring the 
Quality of Health Care, there has been 
a nationwide call for improving quality 
and patient safety. The ultimate legal 
responsibility for hospital quality and 
safety rests with its board. While many 
hospitals have initiated comprehensive 
programs for quality improvement 
in recent years, others - especially 
smaller or unaffiliated hospitals - have 
not paid sufficient attention to these 
critical areas. Although many hospital 
boards are uncomfortable dealing 
with quality, preferring to focus on 
problems of finance and strategy, 
there is a pressing need for hospital 
boards to bring quality to the table. 
The following measures should be 
taken by boards to place quality at the 
forefront of their hospitals’ agendas.  
Educate Trustees:  Trustee education 
is critical for board action on quality. 
Some hospital boards neglect quality 
because they are unaware of the board’s 
legal responsibility for quality, and 
others are hesitant to stir up tension 
between administrative and clinical 
staff. Many trustees fail to act decisively 
on quality issues because they believe, 
incorrectly, that effective quality 
oversight requires a medical degree. 
Elements of an effective education 
program to build trustees’ confidence 
for leadership in quality include:
•  Legal responsibility for quality,
•  Administrator-medical staff relations
•   Definitions, domains, and 
indicators of quality 
Mandated trustee orientation and 
continuing education programs must 
clarify that “oversight of quality” 
requires goal setting, monitoring, 
and corrective action—none of 
which require a medical degree. 
Signal Intent to Lead on Quality:  Once 
trustees are sufficiently educated about 
quality, hospital boards must notify 
the organization of their intent to 
lead on quality. Initially, the hospital 
medical staff may contest the board’s 
authority on quality. The board must 
develop a written statement on quality 
that defines responsibilities and 
distinguishes the board’s role from  
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that of the medical staff. The statement 
should clearly describe how the board 
intends to oversee and direct quality 
programs. Boards also should specify 
the types of quality reports they wish 
to receive (ie, reports with comparative 
benchmarks, executive summaries 
that facilitate the board’s evaluation of 
hospital quality). By requesting changes 
in quality reports, the board signals 
its accountability for quality and its 
intent to refocus priorities accordingly. 
Be Visible on Patient Floors:  Trustees 
seldom visit patient floors, and 
tend to confine themselves to the 
administrative wing of the hospital 
when participating in board meetings. 
This creates a barrier between the 
trustees and patient care departments, 
and reinforces the perception that 
trustees are concerned solely with 
nonclinical issues such as finance 
and strategy rather than quality. 
Leadership in quality requires that 
trustees become visibly involved in 
quality activities (eg, visiting hospital 
floors, talking to patients and care 
providers to understand quality-
related problems). Such involvement 
underlines the board’s commitment to 
quality and empowers nurses and other 
clinical staff who previously may have 
perceived a lack of commitment and 
support at the board level. Presence 
on patient floors also gives trustees an 
opportunity to learn first hand about 
the problems that must be addressed to 
help caregivers improve hospital quality.
Appoint/Empower a Quality Committee:  
A hospital board needs a standing  
committee to monitor quality on its  
behalf. Close to one third of US 
hospital boards have no such 
committee, and many existing quality 
committees meet infrequently, lack 
sufficient power, and/or are dominated 
by members of the medical staff. 
Every hospital should have a quality 
committee with appropriate composi-
tion and sufficient, clearly-delineated 
powers. The quality committee chair-
person and members should be drawn 
from inside and outside the institution, 
and should represent a variety of back-
grounds including medicine, nursing, 
and industrial quality. Partnership 
between the quality committee and the 
hospital’s chief medical officer or chief 
quality officer should be encouraged so 
that the committee remains in touch 
with ongoing quality projects. Serving 
as the eyes, ears, and voice of the board 
on quality, the quality committee must 
receive and monitor quality reports 
on a regular basis and forward recom-
mendations to the board for action.
Establish Goals and Benchmarks:  
Establishing goals and benchmarks  
is necessary to ensure that quality 
improvement is directed toward priority 
areas. The board should oversee the 
establishment of appropriate quality 
standards and peer benchmarks for 
the hospital. The quality committee, 
physicians and nurses on the board, and 
other clinical leaders should provide 
technical advice during goal setting. 
In the face of preventable deaths, 
incremental improvement is hardly an 
appropriate goal. High but achievable 
goals help establish priority and moti-
vate the organization to greater efforts.
Involve Medical Staff and Other 
Clinical Staff:  The board needs 
active cooperation from the 
medical and clinical staff to fulfill 
its responsibilities for quality. The 
board should begin by assessing the 
adequacy of physician involvement: 
Are there adequate physicians on the 
board and its committees? Is there 
adequate physician representation in 
addition to medical staff officers? Are 
forward-thinking physicians being 
recruited to persuade physicians who 
are resistant to change? Physicians 
and other appropriate clinical staff 
should be appointed to the quality 
committee and various task forces on 
quality to benefit from their expertise 
and to reduce resistance to change.
Ensure that Quality Is Part of Strategic 
Planning:  Historically, hospital strategic 
plans have focused almost entirely 
on financial issues. The board must 
incorporate quality-related goals in 
the organization’s strategic plan to 
ensure that quality achievements and 
failures are discussed at the highest 
levels and acted upon. Additionally, 
the board must sanction investment of 
adequate resources in strategic quality 
initiatives including staff, facilities, 
information technology systems, and 
safety-related technology. To this end, 
the board also must promote close 
coordination between the quality 
and strategic planning committees. 
Demonstrate the “Will” to Uphold 
Quality:  As the ultimate authority on 
quality in hospitals, the board must 
sanction unpopular but effective 
quality initiatives - even in the face of 
resistance from the medical staff and 
others. For example, if a hospital hopes 
to improve its mortality rate, the board 
must address controversial issues such 
as how ICUs are organized and staffed, 
or how staff levels are determined. 
Boards are severely tested when 
prominent members of the medical 
staff resist implementing such 
measures. Backing down in these 
instances undermines the hard work 
of physicians and nurses who are 
trying to create a safer environment 
for patients. On the other hand, 
standing by unpopular but effective 
policies sends a strong message 
that the board is resolute about 
advancing patient safety and quality, 
thus reducing future resistance.
Conclusion:  Today’s health care 
environment requires hospital boards to 
play a leadership role in quality.  
To bring quality to the table and  
lead on quality, today’s boards need  
self-education, visibility on the patient 
floor, role clarification on quality, 
empowered quality committees, 
involvement of physicians and clinical 
staff, strategic planning on quality, and 
a demonstrated will to uphold quality.
Kanak Gautam, PhD is Associate 
Professor of Health Management, 
Saint Louis University. He can be 
reached at: gautamk@slu.edu.
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Do improvements in quality of care 
result in improvements in the bottom 
line? To answer this question, we 
need to know the impact of quality 
improvement (QI) on costs and 
revenues, plus the net effect on profits. 
Although the positive impact of 
quality on the bottom line has been 
documented in other industries, there  
is little recent empirical evidence in  
the health care industry.
The business case for health care QI 
(ie, that investments in QI will result  
in better clinical outcomes and better  
financial performance) is primarily 
based on anecdotal evidence from case 
studies. Larger empirical work is about 
10 years old; for example, a study1 of 
more than 1700 hospitals in the late 
1990s concluded that effective imple-
mentation of QI could improve finan-
cial and cost performance. This study 
and others predate quality incentive 
systems such as pay for performance 
(P4P) and nonpayment for preventable 
complications or never events.
Perhaps one of the most important 
breakthroughs in health services 
research in the last 20 years has been 
the growing body of evidence that 
better quality is not necessarily more 
expensive. In consumer product 
markets, we have traditionally  
assumed that higher priced products 
are better quality products. This 
assumption carried over into the 
health care industry until recently, 
when numerous outcomes studies 
documented that it is possible to 
improve quality and reduce costs  
at the same time. What has not  
always been clear is whose costs 
have been reduced – the provider’s,  
the payer’s, and/or the consumer’s.  
This article considers only the  
impact of quality improvement  
on the hospital provider’s costs. 
The impact of better outcomes on 
revenues has not been examined. 
For example, the Premier P4P 
demonstration project documented 
improvements in processes, reductions 
in mortality rates, and decreases in 
associated costs in the demonstration 
hospitals.2 However, no data were 
collected to measure the impact of  
the P4P incentives on revenues or the 
net effect on profits.
 
The Income Statement Perspective:  
To determine the relationship  
between QI and profitability, it is 
necessary to take an income statement 
perspective. The income statement 
represents a summary of financial 
activity over a period of time. The 
bottom line (net income) results from 
subtracting expenses from revenues. 
Although the terms expense and 
cost are often used interchangeably, 
in the language of accounting they  
have different meanings. Studies  
that examine the impact of quality  
of care on hospital costs may actually 
mean hospital expenses. From an 
income statement perspective, the 
question becomes, “How do QI 
programs impact expenses (costs) and 
revenues, and what is the resulting 
impact on income (profits)?” In this 
context, the relevant costs (or expenses) 
are those incurred by the provider of 
care, not the payer or the consumer. 
Impact on Expenses: We start with the 
impact of QI strategies on costs for 
hospitals (ie, the expenses reported 
on the income statement) (Figure 1). 
First, there are expenses associated 
with designing and implementing 
a QI program or complying with 
quality guidelines from a payer. If an 
inpatient hospital QI program results 
in shorter stays, fewer ancillaries, or 
the use of less expensive drugs for a 
given condition, hospital expenses 
will decrease, particularly the variable 
expenses associated with patient 
care. Fixed expenses, primarily staff 
salaries, decrease only if the reduction 
in utilization leads the hospital to 
downsize. On the other hand, if better 
quality of care results in longer stays, 
more ancillaries, and more expensive 
drugs, variable expenses for the hospital 
will increase. Fixed expenses also could 
increase if higher utilization required 
additional staffing or a state mandated 
a lower nurse-to-patient ratio to 
improve quality.
The recent advent of nonpayment 
for preventable complications or 
“never events” raises questions about 
the impact of these payer policies 
on hospital expenses. Presumably, 
complications and never events result 
in higher expenses for the hospital than 
if the complication or event had been 
avoided. Does that imply that a QI 
or patient safety program that targets 
preventable complications or never 
events would result in lower expenses 
for the hospital? The answer is not 
clear, although it should be yes. 
Quality Improvement and the Bottom Line
By Caryl E. Carpenter, MPH, PhD
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+  Expense of designing and implementing 
QI programs
–  Expense from shorter stays, fewer 
ancillaries, or less costly drugs
+  Expense from longer stays, more ancil-
laries, or more costly drugs
+  Expense from changes in nurse 
staffing ratios
– Expense from avoiding “never events”
+  Expense from increased utilization 
resulting from enhanced reputation???
Figure 1. Impact of Quality Improvement  
on Hospital Expenses
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Impact on Revenues: While estimating 
the impact of QI on expenses can be 
difficult, estimating the impact on 
revenues is even more complex. The 
impact on revenues depends on the 
payer (Figure 2). Under a case-based 
reimbursement system such as the 
diagnosis-related groups (DRG) system 
used by Medicare, reducing hospital 
expenses does not result in higher 
revenues. Medicare pays a fixed rate  
per admission based on the diagnosis. 
That rate does not decrease when 
a hospital reduces length of stay or 
services per admission.  
Revenues from payers that use per diem 
reimbursement methods will decrease if 
QI methods result in shorter inpatient 
stays, whereas revenues from these 
payers will increase if QI results in 
longer stays. QI programs that result in 
more or fewer services per day will not 
affect revenues from per diem payers.
Under a P4P system, revenues  
should increase as a hospital complies 
with quality standards and improves 
outcomes of care. The impact of 
nonpayment for never events is 
more ambiguous. Although avoiding 
preventable complications or never 
events will avoid nonpayment and  
a loss of revenues, it will not  
increase revenues.
Many hospital managers believe that 
improvements in quality will result in a 
better reputation for the hospital in the 
community. It could also result in better 
ratings through programs like  
HospitalCompare (www.hospitalc-
ompare.hhs.gov) and HealthGrades  
(www.healthgrades.com). If such 
improvement in reputation results in 
increased utilization of a hospital’s 
services and increased market share, 
the hospital’s QI efforts could increase 
revenues. Unfortunately, it is costly and 
time consuming to measure the increase 
in utilization that can be attributed to 
QI or an enhanced reputation, so these 
measurements are rarely done.
Impact on Income: Hospitals earn 
operating income when their revenues 
exceed expenses. Therefore, the ques-
tion of the impact of QI on profitability 
depends on its net effect on expenses 
and revenues (Figure 3). The effect will 
depend, again, on the method of reim-
bursement. QI that reduces expenses 
will increase income under DRG 
payment; QI that increases expenses 
will decrease income under DRG pay-
ment. However, the net effect of QI on 
profits under per diem payment or P4P 
is unclear. The reduction in expenses 
must be greater than the reduction in 
revenues under per diem payment for 
QI to increase net income. This would 
be most likely to occur if the hospital 
reduced fixed as well as variable  
expense. Similarly, the increased rev-
enue from P4P may or may not exceed 
the reduction in hospital expense, so 
the net effect on profits is ambiguous.
Conclusion: Do improvements in qual-
ity of care result in improvements in 
financial performance? It depends on 
the impact of QI on hospital expenses 
and revenues. That depends, in turn, on 
the type of QI intervention, its impact 
on utilization, and the reimbursement 
method. Conceivably, QI could in-
crease net income for some payers and 
decrease it for others. There is a clear 
need to measure the effects of  
QI carefully in order to answer this 
crucial hospital management question.
Caryl E. Carpenter, MPH, PhD 
is a professor in the Department of 
Management, Health, and Human 
Resources in the School of Business 
Administration at Widener  
University. She can be reached at: 
cecarpenter@widener.edu.
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 No change under DRG reimbursement
    Under per diem payment (depending on 
change in length of stay)
+    Under pay for performance
        No loss of revenue from “never  
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+     Revenue from increased utilization 
resulting from enhanced reputation???
DRG = Diagnosis Related Groups
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Culture is the cornerstone of any 
health care organization. It defines how 
people behave, think, and organize 
themselves to achieve success. The 
essence of culture is rooted in the 
underlying assumptions and beliefs that 
have been jointly learned and taken 
for granted as the organization has 
evolved.1 These assumptions function 
much like a software operating system, 
guiding behavior and thought within 
the organization, often below our level 
of awareness but broadly and deeply 
stabilizing how we work, perform, 
behave, communicate, relate, and 
think. Schein identifies various deep 
underlying assumptions that define a 
culture: the nature of human nature 
(“Is it good or is it evil?”); the nature 
of human relationships (“How should 
we best relate to achieve success?”); the 
nature of time and space (“How do we 
look at time? How does our physical 
layout reflect work style and status?”); 
and the nature of reality and truth (“Are 
you more moralistic or pragmatic in 
your decision making?”).1 The answers 
health care providers and hospital 
board members give to these questions 
determine how the organization is 
structured and organized, what it  
values, how it works and behaves, 
what it rewards and punishes, what it 
considers to be acceptable or ethical, 
and ultimately how healthy the 
organization will be. 
Ethics is defined as the body of 
moral principles or values governing 
a particular culture or group.2 Within 
health care organizations, ethics is 
the outcome of cultural values and 
assumptions related to the practice of 
medicine and patient care. Although 
some people perceive ethics as a 
religious artifact, in reality it is an 
essential part of doing business because 
ethical principles and codes of conduct 
provide a framework for good decision 
making and organizational behavior. 
Ethics serve to link the personal 
beliefs of employees with the corporate 
cultural values and beliefs. Typically 
cultures value honesty, integrity, trust, 
hard work, loyalty and commitment, 
and respect for one another3 - traits that 
are learned through education (eg, the 
organization publicly declares them as 
values) and through observed behavior 
(eg, we see what others do and don’t do 
and the consequences of those actions). 
However, these attributes can be 
compromised if the competing values of 
profit, market share, competition, and 
individualism are also espoused by the 
organization. Within any health care 
providing organization, a culture may 
promote competing values that serve to 
create ethical dilemmas for employees. 
“ Do I provide the patient with  
all available medical options if  
it means costing the hospital  
money and time?”
“ Do I bring the misconduct of a 
coworker to management, or do  
I let it slide to protect the unit  
or team?”
In addition, pressure can be placed  
on employees to compromise ethics  
in an effort to achieve a greater good  
(or value).4  
In a 2003 National Business Ethics 
Survey conducted by the Ethics 
Resource Center,5 the most common 
types of misconduct observed were 
abusive or intimidating behavior 
toward employees, and lying to 
employees, customers, suppliers, and 
the public. These types of misconduct 
can be reinforced culturally and thus 
perpetuate a counterproductive work 
environment. For example, a nurse 
supervisor who regularly berates new 
nurses as a means of controlling staff 
and achieving quality care creates a 
hostile work environment (unethical 
conduct) in the process of achieving 
corporate goals (quality care). If 
she is rewarded by management for 
her performance (quality care), her 
unethical management practices  
are reinforced simultaneously. 
Employees quickly learn what is 
“acceptable behavior” within the greater 
corporate culture and what is truly 
valued. Mistreatment (perceived or 
real) of employees acts as a catalyst for 
unethical workforce behaviors such 
as retaliatory responses (eg, stealing 
supplies, less productive use of time, 
backbiting, noncompliance). In a study 
conducted by Harris Interactive on 
behalf of Deloitte & Touche USA,6 
91% of employed adult workers stated 
that they would more likely behave 
ethically on the job when they have a 
good work/life balance, and 60% said 
that job dissatisfaction is a significant 
reason for people to make unethical 
decisions at work. In fact, people  
do care about ethics and consider  
it an important criterion for a  
healthy workplace.7
When an organization’s culture drifts 
toward unethical practices, the work 
environment becomes less professional, 
productive, satisfying, and safe.8,9  
Unethical cultures (or those with weak 
ethics) create conditions in which 
ethical dilemmas are more common  
and in which personal values are 
consistently challenged.  The resulting 
emotional stress among workers 
contributes to ill health, increased 
turnover, and decreased productivity  
and service quality.10-12 
What Can the Hospital Board Do?:  
Employees listen to their leadership’s 
messages and observe their behavior; 
Ethics, Culture, and the Hospital Board
By P. Michael Peterson, EdD
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therefore, it is incumbent on any health 
care board to define, both in word and 
deed, ethical conduct and to deter-
mine the degree to which ethics are 
a part of the organization’s culture. 
Communication about ethics should 
become a regular part of performance 
reviews, staff meetings, and personal 
conversations. Consistent enforcement 
and reminders of ethical standards 
serve to strengthen the cultural value 
and create a safe environment that 
encourages employees to ask ethics 
questions and get the right answers. 
Creating an Ethical Hospital Board Culture: 
Understanding the existing culture 
is paramount to creating an ethical 
hospital board culture.13 It is difficult 
to know where to go without knowing 
where you are. By taking a close, 
critical, objective look at his or her 
own cultural assumptions and how 
they influence the organization, a 
board member can identify areas for 
growth, improvement, and change. To 
avoid preconceptions and potential 
biases, a cultural assessment should be 
conducted by an external consultant (or 
agency). Internal cultural assessments 
often fail to recognize problems and  
the underlying assumptions. 
Internal systems can be put in place to 
monitor for signs and symptoms of an 
unhealthy organization or workforce. 
Measures that should be consistently 
monitored include absenteeism rates, 
turnover rates, work stress level, 
grievances, communication problems, 
sickness and illness rates, short- and 
long-term disability, accident and safety 
problems, ethics violations, patient 
care quality, and medical mistakes. 
Mandating these actions at the 
organizational level can serve to prevent 
more chronic corporate “diseases.”  
Regular reports to the board on these 
matters should be requested and  
subject to discussion from a cultural  
and ethical perspective.
Leadership is vital for an ethical and 
healthy organization. Therefore board 
members should self-monitor their 
own behaviors, decisions, and practices 
to assure that they align with healthy 
standards of conduct and cultural 
assumptions that promote a healthy 
organization and employee well-being.
Hospital board members should 
not be afraid to challenge long-held 
cultural assumptions. The tendency is 
to perpetuate a given culture because 
it is known, stable, and comfortable. 
However, the culture could be the 
prime cause of institutional problems. 
They should ask themselves, “How is 
our culture impacting our success or 
contributing to ethical problems within 
the organization?”    
P. Michael Peterson, EdD is a professor at 
the University of Delaware and creator of 
the graduate Health Promotion program. 
He can be reached at: pmpeter@udel.edu. 
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The demand for more accountability, 
greater transparency, and better 
performance by the boards that govern 
our nation’s investor-owned and 
nonprofit organizations is growing at 
the federal, state, and local levels. This 
heightened interest in the performance 
of nonprofit organizations and their 
governing boards has stimulated serious 
examination of governance practices. 
Except for requirements established 
by state statutes, the Internal Revenue 
Service, and The Joint Commission, 
formal standards for governance of 
nonprofit health care organizations 
have not been adopted in the United 
States. However, in recent years 
substantial efforts have been made by 
voluntary commissions, panels, and 
others (eg, the American Governance 
and Leadership Group, The 
Governance Institute, and the National 
Center for Healthcare Leadership)  
to describe good governance  
practices and to provide guidance  
for boards and chief executive  
officers (CEOs) to consider as 
benchmarks in evaluating and 
improving governance performance.  
The recent emergence of community-
based health networks or systems 
has transformed the health care 
delivery environment in the United 
States. In various forms – from loose 
affiliations to highly integrated systems 
with centralized governance and 
management – these community-
Nonprofit Community Health System Board Engagement in CEO and Board Evaluation
By Lawrence Prybil, PhD
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based networks or systems encompass 
a substantial and growing proportion 
of the nation’s hospitals and provide a 
considerable volume of inpatient and 
outpatient services. 
 
The governing board of a nonprofit 
hospital or health care system is 
legally and morally responsible for the 
organization, its operations, and the 
services it provides. The board serves 
as the steward of the organization – its 
mission, its assets, and its integrity. The 
basic duties of the board include:
 
1.   Establishing, preserving, and 
reshaping the organization’s 
mission as necessary.
2.   Setting the organization’s 
overall direction by assessing  
the environment, adopting a 
strategic plan, and monitoring  
the organization’s progress  
toward its goals.
3.   Setting quality measures and 
standards and assessing the 
organization’s performance in 
relation to them.
4.   Adopting operating and 
capital budgets and exercising 
financial stewardship.
5.   Ensuring that the organization’s 
charitable and community  
benefit obligations are met.
6.   Ensuring that the organization 
is well managed and complies  
with applicable laws and 
regulations.
7.   Appointing CEOs, setting 
expectations for them, and 
evaluating their performance 
objectively and regularly.
8.   Ensuring that the board has 
the collective knowledge,  
skills, and commitment to do  
its job properly and that board 
self-evaluation is performed 
objectively and regularly.
While the body of knowledge regarding 
governance in general has expanded 
substantially in recent years, there 
is relatively little information about 
governing boards and governance 
practices in community-based health 
care systems. This fact – in combination 
with the heightened interest in  
the duties and performance of 
governing boards and advances  
in formulating benchmarks of  
good governance – provided the 
impetus for a study of governance  
in community health systems. 
Study of Governance in Community  
Health Systems:  An Overview  
The purpose of this study was to 
examine the structures, selected 
practices, and cultures of community 
health system governing boards and 
to compare them with contemporary 
benchmarks of good governance. 
The intent was to identify areas 
where system governance can be 
improved, and to provide helpful 
insights for systems’ CEOs and board 
leaders to assess and enhance board 
effectiveness. For the purposes of the 
study, “community health systems” 
were defined as: “Nonprofit healthcare 
organizations that (1) operate two or 
more general-acute and/or critical access 
hospitals and other healthcare programs in 
a single, contiguous geographic area and 
(2) have a chief executive officer and a 
system-level board of directors who  
provide governance oversight over all  
of these institutions and programs.”
 
The study was designed in 3 phases. 
•   Phase I: Identify a set of 
nonprofit community health  
systems that meet the definition,  
and build a “Community Health 
System Database.”
•   Phase II: Conduct a survey of 
system CEOs to: 1) verify that  
their systems meet the definition; 
2) obtain the CEOs’ perspectives 
on several aspects of their boards’ 
structures, practices, and cultures;  
and 3) compare the findings to 
current benchmarks of good 
governance, and prepare a report. 
•   Phase III: Make on-site visits to a 
subset of the systems to conduct  
in-depth interviews with CEOs  
and board leaders. 
After pretesting with several CEOs, 
a survey was mailed to 210 CEOs 
of community health systems via 
US Postal Service Priority Mail in 
February, 2007. The survey questions 
were limited to those the team  
believed could be answered accurately 
by CEOs without extensive 
investigation. A follow-up mailing  
sent to nonrespondents in March,  
2007, offered the CEOs the option of 
completing the survey electronically. 
Follow-up phone calls were made in 
April and June of 2007 to encourage 
study participation. 
 
The final study population of 
201 nonprofit community health 
systems included 131 independent 
organizations (65%) and 70 
organizations that were part  
of larger regional or national 
organizations (35%). (The 9 CEOs 
whose systems did not meet the 
definition of “community health 
system” were excluded.) The number 
of hospitals in these systems ranged 
from 2 to 9, with an overall average 
of 3.5 general acute and critical access 
hospitals per system. Usable survey 
forms were completed and returned  
by 123 systems (61%). Survey data were 
analyzed in the fall of 2007  
and an initial report was published  
in February of 2008. A summary  
of the findings follows.
 
Summary of Findings Regarding CEO  
and Board Evaluation:  
Evaluating the CEO’s performance 
fairly, objectively, and regularly is 
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beneficial for the CEO, the board, and 
the organization as a whole, and has 
become accepted as a fundamental 
benchmark of good governance. The 
survey data showed that performance 
expectations are established for over 
90% of the CEOs who participated in 
this survey, either by their community 
health system board or – for those with 
parent organizations – at the corporate 
level. As expected, 100% of the  
CEOs reported that financial targets 
were regularly included in their 
performance expectations. 
Responses in other critical areas 
were surprising in a positive sense. 
Monitoring and evaluating the  
quality of patient care and ensuring 
safety of patients, staff, and visitors 
is one of the governing board’s most 
important responsibilities. Close to 
99% of the CEOs surveyed reported 
that patient quality and safety targets  
were regularly included in their 
performance expectations.
Leadership and team building targets 
were included in 68.2% of CEOs’ 
performance expectations, with 
those who head independent systems 
reporting 70.6% compared with 60%  
of those who head systems that are  
part of parent organizations. 
Establishing clear expectations for 
the CEO regarding community benefit 
programs is a good governance practice. 
Ninety percent of the CEOs who 
lead systems that are part of parent 
organizations reported performance 
targets in this area compared with 
only 49% of the CEOs of independent 
systems – a statistically significant 
difference. It is possible that the parent 
corporations encourage or require their 
subsidiary system boards to establish 
specific expectations for their CEOs  
in this important area. 
 
More than 90% of the CEOs reported 
that their community health system 
board or parent organization formally 
evaluates their actual performance in 
relation to the established targets on 
a regular basis – 77.5% annually and 
18.9% every 2 years. When asked their 
opinions about the effectiveness of the 
CEO evaluation process currently in 
place, 95% of the CEOs of systems 
that are part of parent organizations 
perceived that the performance 
evaluation process was fair and 
effective compared with only 66%  
of CEOs of independent systems.  
Most surprising was the finding that, 
although 90.2% of CEOs reported  
that their community health systems’ 
boards engaged in formal assessments 
of how well they carry out their own 
duties on a regular basis, only 55.9% 
reported that the findings were 
employed to make changes intended 
to improve their boards’ structures, 
practices, or culture. 
The next steps will include a further 
analysis of the survey findings and 
an evaluation of the systems’ 3-year 
operating performance data. On-site 
visits will be made to 10 community 
health systems, and 1-on-1 interviews 
will be conducted with board leaders. 
Following these steps, a complete data 
analysis and final study report will be 
published. The full initial report in 
which these findings are discussed  
in detail is as follows:
Prybil L, Levey S, Peterson R, et al. 
Governance in Nonprofit Community 
Health Systems. Chicago, IL: Grant 
Thornton LLP; 2009.
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and Senior Advisor to the Dean of  
the College of Public Health, The 
University of Iowa. He can be reached  
at: Lawrence-prybil@uiowa.edu.
 
NOTE: This survey of chief executive officers was supported 
by a grant from Grant Thornton LLP, which supplemented 
the principal project funding provided by  the W.K. Kellogg 
Foundation, November 13, 2007.
The Future of Boards: White Water Ahead
By Gary Filerman, PhD
As previous articles in this newsletter 
have shown, there are clear indications 
that turbulence lies ahead on the 
governance path. Although the 
signs warn us to heed them and act 
accordingly, health care boards are 
slow to adapt, and providers who serve 
on boards are not known for their 
willingness to lead change. To survive 
and prosper in a constantly changing 
environment, health care delivery 
organizations must be adaptive systems. 
This requires leadership from the 
top – the board level – and there has 
never been a time when provider board 
members have had a more critical role 
to play…if they are well prepared.
 
Can it get more turbulent? Yes, because 
of the diverse pressures that buffet 
organizations, including: 
•   Tensions over appropriate medical 
staff representation in governance
•   Misaligned economic interests 
between the hospital and some 
physicians – or among different 
physician groups
•   Increasing understanding of the 
determinants of quality of care 
that mandates hands-on board 
involvement and response
Other changes also impinge on the 
future of boards; for example: 
•   Medical work. Tasks and 
competencies are being redistributed 
within the medical profession and 
among health care workers.
•   Workforce organizations. The 
traditional adversarial relationship 
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between management and workers 
will dissipate as unionization  
expands and everybody joins  
the patient-centered team.
•   Transparency. It may be a private 
organization, but tax exemption 
will bring the same kind of 
accountabilities (ie, rules) that the 
Sarbanes-Oxely Act of 2002 brought 
to publicly traded companies. 
Physician membership on boards 
has been increasing in recent years. 
I say “membership” rather than 
“representation” because members  
of the board have a primary 
responsibility to the interests of the 
organization. It is a confusing picture 
that will be sorted out – hopefully  
by the boards themselves, but more 
likely by regulation.
Medical Staff Representation in 
Governance:  The relevant questions 
include: 1) how autonomous is the 
hospital medical staff, and 2) what is 
effective medical staff representation 
on the board? Interests, responsibilities, 
and relationships keep changing and 
the structure of the organization must 
adapt to the changes. It was relatively 
simple when most of the doctors were 
independent users of the facility whose 
interests were managed through the 
medical staff organization that they 
controlled. Now there is a substantial 
subset of physicians whose financial  
ties to the institution differentiate  
them from those who maintain the 
traditional relationship. The real or 
perceived differences in interests  
may lead to conflict. 
The ramifications of the quality 
of care revolution on all aspects of 
health professions practice have just 
begun to be felt. It is hard for some 
organizations and practitioners to 
imagine greater impact, or intrusion, 
depending on the perspective. 
Outcomes assessment-driven research 
continues to reveal more ways in 
which the system must change, and 
increases the onus on governance to 
craft and enforce the changes. In simple 
terms, this means changing provider 
behavior, for which the board carries 
unequivocal responsibility. There may 
be a “partnership” with the medical 
staff but, in the eyes of the law and the 
patient, it is an unequal partnership. 
The physician on the board shares 
responsibility with the other members 
to support a culture of quality, to ensure 
that the by-laws adequately address 
quality, and to enforce the by-laws by 
putting the interests of the patient first.
Medical Work:  There are profound 
changes under way in how medical 
work gets done. Outcomes research  
is an important factor, but so are  
the shortages of professionals –  
particularly primary care providers 
– and the increases in the burden 
of chronic disease and the elderly 
population. There is no prospect that 
expanding the number of doctors, 
nurses, and other providers while 
following the present work rules 
(commonly called scope-of-practice) 
will meet the need. 
It is clear that tasks will have to 
be redistributed among providers 
according to the needs of the patient 
and the competencies of providers, and 
not according to the economic interests  
of the professions. How well it works 
will be assessed in terms of patient 
safety, outcomes, and cost-effectiveness 
– not by conformity with outmoded 
licensure laws. 
The Workforce:  The expansion of 
organized labor in health care is an 
important trend with implications 
for the board. Unions are becoming 
more sophisticated in their appeal to 
health workers and have raised moral 
questions about wages and benefits in 
the not unsympathetic public arena. 
It is also important to recognize that 
all of the health professions are turning 
to collective negotiation for economic 
leverage. Unions clearly have a stake 
in quality of care and the strength of 
the institution. Looking forward – a 
key role of the board – a new social 
compact is likely to emerge that goes 
beyond traditional relationships.  
The challenge lies in getting there. 
Transparency: Demands for the 
release of “inside” information 
about quality of care, charges, and 
costs are becoming more insistent 
and duplicative. This “production 
transparency” will continue as pay 
for performance becomes the general 
pattern and the number and scope  
of quality measures continues to 
expand. Governance transparency is 
another matter.
Both for-profit and nonprofit hospitals 
are being swept into the growing 
regulation of the governance function. 
The rationales are different but the 
results are the same. Shareholders’ 
rights are the issue in publicly traded 
systems and the public’s rights are the 
issue in tax exemption. Abuses, rising 
costs, and issues of access and quality 
of care all converge to encourage 
regulators to press for more transparent 
and predictable governance processes.
More Regulation, Not Less:  The mandate 
will be for boards to proactively meet 
the public policy objectives of greater 
accountability and transparency. Boards 
will have less privacy as they wrestle 
with the tensions of interprofessional 
economics and with how to achieve 
greater clarity of responsibility for 
provider competence. 
Boards, especially tax-exempt boards, 
are entrusted with the stewardship  
of resources in the service of the 
mission, whether on behalf of 
stockholders or patients. It is a social 
compact built on trust that has 
diminished. The emerging social 
compact will depend much more on 
regulatory processes. The sources will 
probably be a mix of federal, state,  
local, and even “voluntary” agencies  
(eg, the Joint Commission).
Mandated transparency will be but one 
aspect of greater public accountability. 
Increasingly, boards will be required 
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Reforming Camden’s Health Care System — One Patient at a Time
By Jeffrey Brenner, MD
We are faced with the challenges 
of an aging population, increasing 
numbers of patients with chronic 
illnesses, continually rising health 
care costs, growing numbers of 
uninsured, constrained public budgets, 
and the growing recognition that 
many Americans receive unsafe and 
ineffective care. Our health care 
system stands at the crossroads of 
access, quality, and cost without an 
obvious path forward. Systemic health 
care reform will require new and 
innovative approaches to long-standing 
problems. In Camden, New Jersey, 
an organization called the Camden 
Coalition of Healthcare Providers 
(CCHP) has begun to reframe the 
questions and look for better answers. 
Camden, a small city with 3 hospitals 
in 9 square miles, has the dubious 
distinction of being at the top of 2 
lists:  it is the poorest city in the United 
States according to 2005 census data,1 
and it was named the “most dangerous 
city in the United States” by the 
Morgan-Quitno report in 2003. Once 
a thriving center of manufacturing and 
industrial commerce, the city’s economy 
and social infrastructure have collapsed 
over the last 50 years. Currently, 44% 
of families live below the federal 
poverty level and the city’s population 
of 79,000 is quite young (median age = 
27 years).1  The city government, police 
department, and school system are 
under varying levels of state takeover 
due to a history of corruption and 
poor performance. Ironically, a place 
like Camden may hold the keys to 
reinventing the health care delivery 
system – to make it safer, more cost-
effective, and more patient-centered.
Five years ago, CCHP began building 
a citywide health database using 
claims data from the 3 local hospitals. 
The database now contains the 
name, address, date of birth, date of 
admission, insurance status, diagnosis 
codes, charges, and receipts for every 
Camden City resident who has been 
to a local hospital or emergency room 
(ER) from 2002 through 2007.  
From these data we have learned 
that, in a single year, 50% of the city’s 
residents use an ER or hospital - twice 
the national rate. The leading utilizer 
averaged 113 visits a year. The vast 
majority of these visits are for acute 
and chronic problems that could be 
prevented with better access to  
primary care. 
 
According to internal data collected 
from 2002 to 2007, 13% of the patients 
accounted for 80% of the costs (mostly 
to Medicaid and Medicare) and 20% 
of the patients generated 90% of the 
costs. The most expensive patient 
had $3.5 million in receipts. The top 
1% of patients (1035 residents) went 
to the ER and hospital between 24 
and 324 times. The $46 million that 
hospitals received for the care of these 
patients would be sufficient to fund 
approximately 100 primary care nurse 
practitioners (NP), with each NP 
caring for just 10 patients.
 
The database was a crucial first step in 
galvanizing support for CCHP from 
local stakeholders and foundations. 
Currently, CCHP has 3 main projects: 
a Citywide Care Management Project 
targeting “super utilizers” of the local 
ERs and hospitals; a Primary Care 
Capacity Building Project to assist 
local offices with practice improvement 
efforts; and a Web portal to improve 
efficiency and coordination of care. 
Implemented in September 2007, 
the Citywide Care Management 
Project now has 60 patients enrolled. 
Patients are referred by physicians, 
nurses, and social workers at the local 
hospitals, and by several Medicaid 
health maintenance organizations 
(HMOs). A family physician, NP, 
community health worker, and 
social worker staff the project, which 
provides “transitional” primary care 
to patients because most have no 
existing relationship with a primary 
care provider. These patients have 
significant barriers to care including: 
homelessness, substance abuse, severe 
chronic illnesses, physical disability, and 
mental health problems. Project staff 
help patients fill their prescriptions, 
apply for long-term disability, enroll in 
a medical day program, find appropriate 
housing, get a bed in the homeless 
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to define their own operating rules 
and held accountable for playing by 
those rules. This trend has serious 
implications for physician board 
members whose representative 
function and participation will come 
under scrutiny. Boards must be very 
sensitive to this trend and proactive in 
addressing all identifiable questions  
of real or apparent conflict of interest.
Steering through the coming white 
water demands the deliberate,  
proactive attention of boards. In 
particular, clinician board members  
will be expected to clarify their roles 
and provide expert guidance as the 
board engages the rapids.
Gary Filerman, PhD is Professor and 
Chair of the Department of Health 
Systems Administration at Georgetown 
University. He can be reached at:  
glf3@georgetown.edu.
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shelter, coordinate legal issues, find 
transportation, treat depression, manage 
chronic illnesses like diabetes, and 
coordinate appropriate testing/specialty 
care. The patients are monitored 
wherever they go: hospital, nursing 
home, medical day program, street 
corner, or homeless shelter.
 
The chief advantage of a citywide  
coalition is its ability to encourage  
collaboration and data sharing 
among hospitals, to identify common 
challenges, and to address the 
challenges with coordinated solutions. 
One successful strategy has been 
to organize a monthly Citywide 
Care Management Coordinating 
Meeting that is attended by social 
workers, ER physicians, hospitalists, 
and community-based physicians 
from across the city. An electronic 
health record (EHR) system is 
used to systemically track the care 
of our patients. Eventually, local 
ERs, hospital-based physicians, and 
Medicaid HMO care management 
staff will have access to the system  
as well. 
 
We are currently managing 90 patients 
and have enough data on 36 patients, 
before and after the project, to begin 
analyzing outcomes. The citywide 
health database allows us to track 
5 years’ worth of hospital and ER 
claims prior to the intervention. Our 
system of soliciting referrals from 
local physicians and social workers 
has correctly identified and enrolled 
in our project (Figure 1). Our project 
tracking data shows an initial decrease 
in their utilization parameters and an 
improvement in their collections rate. 
Once we have a year of data we can 
begin the statistical analysis necessary 
to correct for problems in data like 
regression to the mean.
 
Like any maladaptive health behavior, 
it takes time and compassion to 
effect positive change in patterns of 
utilization. These patients don’t want 
to go to the hospital – they just don’t 
know how to get their needs met. After 
a few months of twice-weekly outreach 
visits, hospital utilization often drops 
significantly. Patients like these are not 
unique to Camden. Such patients are 
well known to every hospital and ER  
in every city in the country. 
 
For much of Camden’s population, 
reducing ER and hospital utilization 
will require transforming local 
primary care offices into high-
performing, modern, patient-centered 
medical homes, with features like 
multidisciplinary care teams, EHRs, 
open-access scheduling, and patient 
registries. The primary care providers 
and clinics that operate in underserved 
communities struggle to keep their 
offices open. Unsafe communities, 
break-ins, low reimbursement rates, 
complex patients, and difficult 
insurance requirements create 
monumental challenges to providing 
high-quality care. Our Coalition 
has begun laying the groundwork 
for transitioning local practices into 
NCQA-certified medical homes2 
through monthly office manager 
meetings, provider education programs, 
individual practice assessments, and 
technical assistance. 
 
Political scientists observe that systems 
in urban communities (ie, public health, 
safety, education) become insular, self-
perpetuating, and resistant to change. A 
study of the education performance and 
civic capacity of 11 cities found that 
sustained improvements were achieved 
as a result of many years of sustained 
efforts by a stable group of stakeholders. 
The CCHP exemplifies the type of 
local multi-stakeholder coalition that 
Measured as rates per month before and after intervention at a 1:1 ratio 
N=36 patients
Outcome Measure Before After Absolute Change Percent Change
Charges 1,218,009.69 531,202.91 686,806.78 56.39%
Receipts 83,992.29 55,641.94 28,350.35 33.75%
Collections rate 6.90% 10.47% 3.58% 51.90%
Emergency Visits 43.532 29.363 14.169 32.55%
Inpatient Visits 18.063 7.850 10.214 56.54%
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Figure 1. Initial Project Outcomes for Patients in Citywide Care Management Project
(continued on page 16)
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will be critical to nationwide reform 
of our health care system. There are 
multiple efforts across the country to 
build similar organizations.
 
A small, poor city like Camden is an 
excellent laboratory for understanding 
what is broken in our health care 
delivery system and for piloting 
practice-level, hospital-level, and 
community-wide solutions. 
Unnecessary utilization and poor 
health outcomes in urban communities 
represent a systemic failure to build a 
well-funded, accessible, high-quality, 
proactive, coordinated, data-driven 
health care delivery system with 
a strong primary care base that is 
connected to the local network of 
community-based social services.  
We are working to build such a  
system – one “super utilizer” at a time.
Jeffrey Brenner, MD is Clinical Instructor 
in Family Medicine at the Robert Wood 
Johnson Medical School in Camden,  
New Jersey. He can be reached at:  
jeffrey.brenner@verizon.net. 
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Physician Quality Reporting Initiative (PQRI): Theory and Practice
By Bettina Berman, RN
Background:  Medicare, the nation’s 
single largest health care purchaser, 
pays for health care services for almost 
45 million beneficiaries1 – a number 
that is expected to swell in the coming 
decade. Current Medicare expenditures 
represent 14% of federal spending,  
and the projected annual growth rate  
is 7.5% between 2008 and 2017.1 
In light of this, the financial viability  
of Medicare and payment reform  
will likely continue to dominate 
future health policy discussions in  
the United States. 
 
For several years, research has 
demonstrated that more, and more 
expensive, health care is not necessarily 
better health care. A recent policy brief 
issued by the Dartmouth Institute for 
Health Policy and Clinical Practice 
reported that the geographical 
variations in Medicare spending are 
almost entirely explained by differences 
in the volume of Medicare services 
rendered to beneficiaries. Perhaps  
more compelling are findings that a 
higher volume of services and higher 
spending do not produce better 
outcomes of care.2 
 
In 2005, the Centers for Medicare  
and Medicaid Services (CMS) issued 
its Quality Roadmap with strategies  
for achieving higher health care  
quality for Medicare beneficiaries  
while curtailing skyrocketing health 
care costs. One of these strategies –  
Value-Based Purchasing (VBP) – 
sought to transform Medicare from 
a passive payer to an active purchaser 
of high-quality efficient care. CMS 
considers VBP to be the basis for all 
future Medicare reimbursement and 
payment systems. 
 
The cornerstones of VBP are: 
development of clinical, evidence-
based measures; resource utilization 
measurement; and payment  
system redesign.3
Physician Quality Reporting Initiative 
(PQRI):  The Tax Relief and Health 
Care Act of 2006 formed the  
legislative background for the  
PQRI program, one of several  
VBP initiatives implemented by  
CMS. Officially launched on  
July 1, 2007, PQRI consists of 
processes, outcomes, and structural 
measures used to assess evidence- 
based standards of clinical care.  
The Medicare Improvements for  
Patients and Providers Act of 2008 
(MIPPA) made the PQRI program 
permanent and required that, by  
2010, CMS develop a more 
comprehensive plan for VBP 
that includes measures, incentive 
methodology, data strategy and 
infrastructure, and public reporting.
Currently a voluntary pay-for-reporting 
quality initiative, PQRI is widely 
regarded as a precursor to a federal  
pay-for-performance (P4P) program 
for individual Medicare providers.  
Now in its third year, the program 
offers physician and nonphysician 
providers a financial incentive in  
return for submitting quality-based 
G-codes (ie, Medicare-specific codes) 
or Current Procedural Technology-II 
claims codes. 
The 2009 PQRI consists of 153  
unique quality measures and 7 quality 
measures groups related to patient 
care provided in both the inpatient 
and outpatient settings. In 2009, new 
individual measures were introduced 
in the areas of HIV, back pain, and 
preventive care, and options for 
reporting on measures groups were 
expanded to include preventive 
care, coronary artery bypass graft, 
rheumatoid arthritis, perioperative  
care, and back pain. 
 
Eligible professionals include physician 
and nonphysician providers who  
accept Medicare Part B payment  
and hold an active National Provider 
Identifier. The payment incentive for 
2009 is 2% of total allowed charges  
for covered services furnished during  
a reporting period (ie, January 1- 
December 31, 2009 for all measures, 
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and a July 1-December 31, 2009  
option for registry and measures  
group-based reporting).4  
 
In 2009, the measure for electronic 
prescribing (e-Rx) became a separate 
VBP-P4P initiative under CMS,  
offering an additional 2% financial  
incentive to physicians who utilize  
e-Rx in the outpatient setting. 
Providers who fail to meet e-Rx 
requirements will be faced with a 
reduction in payment starting  
in 2012.5
 
In addition to the small financial 
incentive, early adopters of PQRI 
have benefited from their experience 
with the program’s structure and 
have provided CMS and the measure 
developers with feedback on the 
quality measures and the program 
methodology. Such an understanding 
of the framework for a national quality-
reporting program prepares providers 
for future programs.6 Although the 
release of the initial provider report 
from CMS revealed some systemic  
and methodologic issues, providers  
are likely to gain useful benchmarking 
data from future reports. 
Experience with the PQRI Program at 
Jefferson University Physicians (JUP) 
Faculty Practice Plan:  JUP is a faculty 
practice plan of 450 primary care and 
specialty physicians in 19 practices. 
Recognizing the need to measure and 
improve quality of outpatient care, 
the JUP Clinical Care Subcommittee 
(CCS) focuses on creating a JUP-wide 
quality and safety culture, monitoring 
national and local trends in quality 
management and P4P, selecting and 
developing quality measures and 
initiatives in alignment with nationally 
endorsed measures, and stimulating 
performance improvement.
 
The CMS PQRI program was imple-
mented as a JUP-wide performance 
project in 2006. Primary care practices 
were the first to identify measures for 
reporting, and practice participation 
grew as additional subspecialty mea-
sures became available. Of 200 physi-
cians (15 practices) who participated  
in the 2007 program, approximately 
50% qualified for a bonus payment.  
The CCS expects that all 19 practices 
will have submitted PQRI measures  
to CMS by late spring of 2009. 
 
Implementing the PQRI program 
across 19 faculty practices was a  
complex undertaking that required 
strong efforts from interdisciplinary 
teams. Barriers were abundant;  
for example:
•   Professional and nonprofessional 
education was needed regarding the 
program concept and the new  
lexicon of quality codes.
•  Complex measure specifications 
presented difficulties.
•  The existing infrastructure was 
insufficient to support reporting 
requirements and changes to current 
workflow processes. 
•  Physician buy-in issues were related 
to the size of the financial incentive, 
the increase in workload, and accep-
tance of quality measures as accurate 
indicators of quality patient care. 
•  Lack of transparency of the 
algorithm used for reporting 
compliance and lack of timely 
feedback reports from CMS  
created delays in providing 
meaningful feedback to practices. 
While many of the barriers encountered 
by the JUP practices were similar to  
the nationwide findings by CMS, a  
key factor to successful PQRI imple-
mentation across JUP has been the 
collaboration between representatives 
from the practices, JUP administration, 
and the JUP performance improvement 
team. Continued support from CMS  
in terms of national provider calls,  
information posted on the CMS  
Web site, and clarification of questions 
via email has been invaluable to the 
success and the expansion of the  
program across the faculty practices. 
 
It will be interesting to see where the 
CMS Quality Roadmap will lead us 
in the future. The CMS plan for a 
VBP program for Medicare payment 
for professional services, required by 
MIPPA legislation, is due in less than  
a year (May 2010). 
Bettina Berman, RN, is Project Director 
for Quality Improvement at the Jefferson 
School of Population Health. She can be 
reached at: bettina.berman@jefferson.edu.
References:
1.    Kaiser Family Foundation. Medicare spending and 
financing fact sheet. Publication #7305-03. Available at: 
http://kff.org/medicare/upload/7305_03.pdf.
2.    Fisher E, Goodman D, Skinner J, Bronner K. Health care 
spending, quality, and outcomes. More isn’t always better. 
The Dartmouth Institute for Health Policy and Clinical 
Practice. Available at: http://www.dartmouthatlas.org/
atlases/Spending_Brief_022709.pdf. 
3.    Centers for Medicare and Medicaid Services. Roadmap 
for quality measurement in the traditional Medicare fee-for-
service program. Available at: http://www.cms.hhs.gov/
QualityInitiativesGenInfo/downloads/VBPRoadmap_
OEA_1-16_508.pdf. Accessed April 9, 2009.
4.    Centers for Medicare and Medicaid Services. 
Physician quality reporting initiative. Available at: 
http://www.cms.hhs.gov/pqri/. Accessed April 3, 2009. 
5.    Centers for Medicare and Medicaid Services. Electronic 
prescribing incentive fact sheet. Available at: http://www.
cms.hhs.gov/ERxIncentive/Downloads/erx_incentive_
program_simple_factsheet.pdf. Accessed April 3, 2009. 
6.    Gaspar KG, Sherellen G, Weygandt P. Physicians as 
stakeholders in health care: PQRI is an opportunity to 
participate. Primary Care Reports. 2008;14(2):13-24. 
17Prescriptions for Excellence in Health Care
This newsletter was jointly developed and subject to editorial review by Jefferson School of Population Health and Lilly USA, LLC, and is supported through funding by Lilly USA, LLC. 
Improving Quality and Safety Through Convenient Care Clinics
The need for accessible, affordable, 
quality health care in the United States 
has never been greater. Convenient 
Care Clinics (CCCs) were created in 
response to challenges faced by the 
current health care delivery system –  
a shortage of primary care providers, 
decreased access to basic primary  
health care, and high costs – all of 
which compromise quality. 
 
CCCs are small, consumer-driven, 
retail-based clinics that provide basic 
and preventive health care services to 
all populations and sociodemographic 
segments 7 days a week, including 
evenings and holidays. Practicing 
evidence-based medicine, CCCs’ 
staff – usually nurse practitioners 
(NPs) or physician assistants (PAs) 
and physicians – diagnose and treat 
common health problems, triage 
patients to appropriate levels of care, 
advocate for a medical home for all 
patients, and reduce unnecessary  
visits to emergency rooms. 
 
CCCs strive to integrate their services 
with those of the local medical 
community. In particular, they actively 
work to connect CCC patients with 
a primary care physician (PCP). To 
date, more than 1000 CCCs across the 
country have provided care to more 
than 3.5 million patients. Because 
nearly one third of CCC patients 
– and 40 million Americans overall – 
report not having a PCP, CCCs are 
in a position to improve the quality of 
public health by facilitating proactive 
and prevention-minded health care.  
 
Quality care and quality assurance are 
critical to the long-term survival of 
CCCs. Standardized protocols and 
nationally accepted evidence-based 
guidelines generally are built in to the 
electronic heath records (EHRs) that 
CCC providers use as tools to enhance 
the clinical decision-making process. 
Among the professional organizations 
whose guidelines are incorporated by 
CCCs are the American Academy 
of Pediatrics, the American Medical 
Association, and the American 
Academy of Family Physicians. 
 
CCCs incorporate rigorous quality 
assessments in their evaluative 
structures including formal chart 
reviews by collaborating physicians, 
peer review by NPs and PAs, and 
standard coding audits. Most clinics  
use proprietary software systems, 
EHRs, and other technology to 
optimize the patient experience and 
facilitate continuity of care within  
the medical community. 
 
In general, CCCs follow established 
protocols to ensure a high level of care 
and patient satisfaction. On arrival 
at a clinic, patients register to be 
seen, sometimes using a touch-screen 
computer terminal (similar to an airline 
self-check-in kiosk) into which they 
enter basic demographic information 
and the reason for their visit. This 
sign-in process is the beginning of 
the patient’s EHR. In some cases, 
this information is transmitted 
electronically to a computer terminal 
inside the treatment room, where a 
provider is notified that a patient is 
waiting to be seen. Once the patient is 
escorted to the exam room, the provider 
validates the information provided 
by the patient at check-in and enters 
additional medical information  
about the patient’s symptoms and 
conditions, as well as any pertinent 
medical history. 
 
In October 2006, industry leaders 
formed the Convenient Care 
Association (CCA), a nonprofit 
corporation that brings CCC providers 
and business leaders together with the 
goal of assuring that this new model  
of care remains focused on quality 
service, accessibility, and affordability. 
The CCA launched industry-wide 
quality and safety standards in March 
of 2007. Developed with the guidance 
of a clinical advisory board and with 
direct input from the leadership of 
medical and nursing groups, these 
standards were designed to be more 
stringent than those adopted by key 
medical associations. Mandatory 
adherence to these common standards 
for operation helps ensure uniform  
quality across all CCCs. 
 
The ongoing training and process 
improvement required by CCA stan-
dards help CCCs to maintain quality 
and continuity of care and to foster 
activities (eg, communication of clinical 
outcomes and satisfaction rates) that 
improve continuity and quality. The 
standards are built on the foundation 
that creating synergies with traditional 
medical service providers also will 
improve continuity and overall quality. 
The following is an excerpt from the 
CCA quality and safety standards:
•   All providers are credentialed and 
follow state licensing requirements.
•   CCA members are committed 
to monitoring quality on an  
ongoing basis.
•   CCA members build relationships 
with traditional health care providers 
and hospitals, and, when permitted, 
share patient information and  
ensure continuity of care.
•   CCA members encourage patients to 
have a regular source of primary care.
•   CCA members are in compliance 
with state and federal regulations 
(Occupational Safety and Health 
Administration [OSHA], Clinical 
Laboratory Improvement Amend-
ments [CLIA], Health Insurance 
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Portability and Accountability  
Act [HIPAA], Americans with  
Disabilities Act [ADA], Centers  
for Disease Control [CDC]).
•   CCA members provide an environ-
ment that is conducive to quality 
patient care and meet standards for 
infection control and safety.
In Table 1, the CCA standards are 
compared to retail-based CCC 
guidelines developed by key medical 
professional associations. 
CCA has contracted with the Jefferson 
School of Population Health to 
establish a process whereby CCA 
members who demonstrate adherence 
to quality standards may become 
certified. The certification process 
entails an initial assessment of written 
policies and procedures and subsequent 
reviews of CCA member operations  
to assure continued adherence to 
quality standards. CCA recognizes 
member clinic certification awarded  
by other national accrediting bodies  
(eg, The Joint Commission). 
 
Collectively, CCCs have reported 
positive outcomes. A recent study 
published in the American Journal of 
Medical Quality showed an overall 
99.05% adherence by CCC providers 
to clinical guidelines for treating acute 
pharyngitis, a rate that is significantly 
higher than adherence rates reported 
elsewhere.1 A May, 2008 Harris 
Interactive poll published in the  
Wall Street Journal reported that 90% 
of CCC patients are satisfied with  
the quality of their care.2 
 
In conclusion, CCCs have evolved at 
a time when our health care system is 
floundering. CCCs focus on quality, 
convenience, and consumer choice.  
Competent professional health care 
providers, use of evidence-based 
practices in patient care, established 
quality standards, and ongoing quality 
improvement mechanisms are central 
to the CCC concept. Because of this, 
CCCs are proving to be an accessible, 
affordable, and high-quality health  
care choice.
Tine Hansen-Turton, MGA, JD is 
Executive Director of the CCA.  She  
can be reached at: tine@ccaclinics.org.
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AAFP= American Association of Family Practitioners AAP=American Academy of Pediatrics AMA= American Medical Association CCA= Convenient Care Association
Category Quality Standards Comparison AAFP AAP AMA CCA 
Scope of Practice Well-defined •  • • 
  Limited •  • • 
Practice Guidelines Evidence-based • • • •  
  Continuity of care •  • •
Team-based Approach Compliance with practitioner oversight requirements • • • • 
  Out of scope •  • • 
  Follow-on care •  • •
Referrals Encourage medical home • • • • 
  Emergency response procedures •   •
Electronic Health Record Data aggregation •  • • 
  Integration •  • •
Provider Credentialing All practitioners   • • 
  Peer review    • 
  Collaborating physician review    •
Quality Monitoring Compliance with evidence-based guidelines •   • 
  Quality and safety outcome analysis    • 
  Patient satisfaction analysis    • 
  Occupational Safety and Health Administration   • • 
  Clinical Laboratory Improvement Amendments    •
Compliance Health Insurance Portability and Accountability Act    • 
  Americans with Disabilities Act     • 
  Centers for Disease Control Infection Control Guidelines  • • •
Consumer Empowerment Price Health care choices    • 
  Consumer transparency    • 
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Table 1. Comparison of CCA Standards with Other Professional Association Standards
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